Forty patients with cirrhosis and PHT ( hepatic venous pressure gradient ( HVPG ) 10mmHg ) were randomly allocated to receive sapropterin ( n = 19 ) for 2 weeks ( 5mg/kg/day increased to 10 at day 8 ) or placebo ( n = 21 ) in a double-blind multicenter clinical trial .